That same 20 units at 10 mg/mL would only deliver 2 mg
GHK-Cu injectable removed from Category 2
GLP-1 medications are becoming one of the most important workplace health and benefits topics
Both Wegovy and Zepbound offer powerful tools for managing weight, improving health, and feeling your best
Originally developed for treating diabetes, tirzepatide has shown significant effectiveness as an obesity treatment, helping patients achieve meaningful weight reduction while improving overall metabolic function
In a randomized trial using PET-MRI to assess carotid plaque inflammation, semaglutide did not show a significant difference versus placebo on the prespecified primary plaque-inflammation endpointslikely influenced by low baseline inflammatory burden in a well-treated population. How to interpret this: Imaging studies like this are helpful for understanding mechanisms and terminology (e.g., atherosclerotic inflammation, PET-MRI plaque imaging), but they do not establish semaglutide as a direct vascular inflammation imaging reducer in general clinical use based on current evidence. 5) They Improve Kidney Outcomes in High-Risk Populations (Semaglutide) By improving glycemic control and metabolic stress, GLP-1 therapies can reduce kidney risk in susceptible patients